Exciting news. Blabs leads a 10 million dollar seed round in our new company Flashpoint Therapeutics. They have been outstanding partners and also coinvested alongside Dupont in Azul 3D and their revolutionary High Area Rapid Printing (HARP) technology! Beta Lab بيتا لاب Azul 3D